Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib Cream in Children With Nonsegmental Vitiligo
NCT06804811Phase 3Recruiting
- Sponsor
- Incyte
- Start
- Nov 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of ruxolitinib cream in nonsegmental vitiligo (NSV), sponsored by Incyte. Started Nov 2025; status: recruiting.
02
Drugs
ruxolitinib cream
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT06804811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06804811.